Sarasin & Partners’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-6,106,507
Closed -$68M 87
2022
Q4
$68M Sell
6,106,507
-507,489
-8% -$5.9M 0.89% 38
2022
Q3
$78.4M Sell
6,613,996
-3,092
-0% -$46.8K 1.09% 37
2022
Q2
$101M Buy
6,617,088
+1,363,968
+26% +$24.5M 1.27% 34
2022
Q1
$111M Buy
5,253,120
+3,776,816
+256% +$81.4M 1.12% 35
2021
Q4
$34.9M Buy
1,476,304
+806,796
+121% +$17.3M 0.32% 55
2021
Q3
$13.4M Sell
669,508
-29
-0% -$594 0.14% 63
2021
Q2
$13.5M Buy
+669,537
New +$14.3M 0.14% 62

Other funds holding MPT

Sarasin & Partners's MPT Position: Q1 2023 in Review

Sarasin & Partners sold out of Medical Properties Trust (MPT) in Q1 2023, closing a stake of 6,106,507 shares — an estimated $68M sold.

Sarasin & Partners first reported a position in MPT in Q2 2021 and held it in 7 quarters. The position peaked at $111M in Q1 2022. 628 funds tracked by Wall St. Rank hold MPT as of Q1 2023.

  • Sarasin & Partners reported no remaining Medical Properties Trust position as of Q1 2023 after selling out during the quarter.
  • Sarasin & Partners sold 6,106,507 Medical Properties Trust shares in Q1 2023, an estimated $68M.
  • Sarasin & Partners first reported a position in Medical Properties Trust in Q2 2021 and held it in 7 quarters.
  • Sarasin & Partners's Medical Properties Trust position peaked at $111M in Q1 2022.
  • 628 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2023.

Based on Sarasin & Partners's 13F filing for Q1 2023, filed 27 Apr 2023.